Chemical Biology & Drug Design · 2018 · 23 citations · 26 references
PharmacyMedicinal ChemistryPharmacologyDrug DiscoveryPharmacodynamicsStructure-activity RelationshipsAntifungal AgentsAntimicrobial PharmacodynamicsQuantitative Structure-activity RelationshipsStructure-activity Relationship AnalysisAntifungal PharmacodynamicsBroth MicrodilutionMedicinal Chemistry ApplicationsMinimum Inhibitory Concentration ModelingNew Antifungal AgentsPharmacodynamics Of Antifungal DrugsTime-kill AssaysTime-kill Kinetics
Abstract The combination of tools such as time‐kill assay with subsequent application of mathematical modeling can clarify the potential of new antimicrobial compounds, since minimal inhibitory concentration ( MIC ) value does not provide a very detailed characterization of antimicrobial activity. Recently, our group has reported that the 8‐hydroxy‐5‐quinolinesulfonic acid presents relevant antifungal activity. However, its intrinsic acidity could lead to an ionization process, decreasing fungal cell permeability. To overcome this potential problem and enhance activity, the purpose of this study was to synthesize and evaluate a novel series of hybrids between the 8‐hydroxyquinoline core and sulfonamide and to prove their potential using broth microdilution method, obtaining the pharmacodynamic parameters of the most active derivatives combining time‐kill studies and mathematical modeling and evaluating their toxicity. Compound 5a was the most potent, being active against all the fungal species tested, with low toxicity in normal cells. 5a and 5b have presented important antibacterial activity against Staphylococcus aureus strain. The EC 50 values obtained by combination of time‐kill studies with mathematical model were similar to those of MIC , which confirms the potential of compounds. In addition, these derivatives are non‐irritant molecules with the absence of topical toxicity. Finally, 5a and 5b are promising candidates for treatment of dermatomycosis and candidiasis.
26
Sulfonamide resistance: mechanisms and trends
Ola Sköld · Drug Resistance Updates · 2000 · 636 citations
Di Chen, Qiuzhi Cindy Cui, Huanjie Yang et al. · Cancer Research · 2007 · 211 citations
Medicine, Oncology, Pharmacology +13